Literature DB >> 17982024

Cutting edge: Rac GTPases sensitize activated T cells to die via Fas.

Madhu Ramaswamy1, Celine Dumont, Anthony C Cruz, Jagan R Muppidi, Timothy S Gomez, Daniel D Billadeau, Victor L J Tybulewicz, Richard M Siegel.   

Abstract

In activated CD4(+) T cells, TCR restimulation triggers apoptosis that depends on interactions between the death receptor Fas and its ligand, FasL. This process, termed restimulation-induced cell death (RICD), is a mechanism of peripheral immune tolerance. TCR signaling sensitizes activated T cells to Fas-mediated apoptosis, but what pathways mediate this process are not known. In this study we identify the Rho GTPases Rac1 and Rac2 as essential components in restimulation-induced cell death. RNA interference-mediated knockdown of Rac GTPases greatly reduced Fas-dependent, TCR-induced apoptosis. The ability of Rac1 to sensitize T cells to Fas-induced apoptosis correlated with Rac-mediated cytoskeletal reorganization, dephosphorylation of the ERM (ezrin/radixin/moesin) family of cytoskeletal linker proteins, and the translocation of Fas to lipid raft microdomains. In primary activated CD4(+) T cells, Rac1 and Rac2 were independently required for maximal TCR-induced apoptosis. Activating Rac signaling may be a novel way to sensitize chronically stimulated lymphocytes to Fas-induced apoptosis, an important goal in the treatment of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982024     DOI: 10.4049/jimmunol.179.10.6384

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 3.  Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.

Authors:  Madhu Ramaswamy; Min Deng; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

Review 4.  The diverse roles of Rac signaling in tumorigenesis.

Authors:  Natalie A Mack; Helen J Whalley; Sonia Castillo-Lluva; Angeliki Malliri
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

5.  Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages.

Authors:  Ritsuko Oura; Rieko Arakaki; Akiko Yamada; Yasusei Kudo; Eiji Tanaka; Yoshio Hayashi; Naozumi Ishimaru
Journal:  J Immunol       Date:  2012-12-19       Impact factor: 5.422

Review 6.  Age-related defects in the cytoskeleton signaling pathways of CD4 T cells.

Authors:  Gonzalo G Garcia; Richard A Miller
Journal:  Ageing Res Rev       Date:  2009-11-24       Impact factor: 10.895

7.  Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Authors:  Andrew L Snow; Rebecca A Marsh; Scott M Krummey; Philip Roehrs; Lisa R Young; Kejian Zhang; Jack van Hoff; Deepali Dhar; Kim E Nichols; Alexandra H Filipovich; Helen C Su; Jack J Bleesing; Michael J Lenardo
Journal:  J Clin Invest       Date:  2009-09-14       Impact factor: 14.808

Review 8.  Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.

Authors:  Madhu Ramaswamy; Sophia Y Cleland; Anthony C Cruz; Richard M Siegel
Journal:  Results Probl Cell Differ       Date:  2009

Review 9.  microRNAs and death receptors.

Authors:  Sun-Mi Park; Marcus E Peter
Journal:  Cytokine Growth Factor Rev       Date:  2008-05-19       Impact factor: 7.638

10.  A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth.

Authors:  Wenjing Ruan; Christopher T Lee; Julie Desbarats
Journal:  Mol Biol Cell       Date:  2008-05-28       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.